Exane Derivatives’s DBV Technologies S.A. American Depositary Shares DBVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$258 Hold
10
– – ﹤0.01% 652
2022
Q1
$161 Hold
10
– – ﹤0.01% 974
2021
Q4
$162 Hold
10
– – ﹤0.01% 849
2021
Q3
$495 Hold
10
– – ﹤0.01% 939
2021
Q2
$529 Hold
10
– – ﹤0.01% 937
2021
Q1
$538 Sell
10
-190
-95% -$10.1K ﹤0.01% 792
2020
Q4
$5.24K Buy
200
+116
+138% +$2.57K ﹤0.01% 557
2020
Q3
$1.45K Sell
84
-1,216
-94% -$34.9K ﹤0.01% 589
2020
Q2
$57.1K Hold
1,300
– – 0.02% 343
2020
Q1
$51K Buy
+1,300
New +$117K 0.01% 350

Other funds holding DBVT

Exane Derivatives's DBVT Position: Q2 2022 in Review

Exane Derivatives held its DBV Technologies S.A. American Depositary Shares (DBVT) position steady in Q2 2022 at 10 shares worth $258. The position accounts for ﹤0.01% of the portfolio, ranked #652.

Exane Derivatives first reported a position in DBVT in Q1 2020 and has held it in 10 quarters since. The position peaked at $57.1K in Q2 2020. 38 funds tracked by Wall St. Rank hold DBVT as of Q2 2022.

  • Exane Derivatives held 10 shares of DBV Technologies S.A. American Depositary Shares worth $258 as of Q2 2022.
  • Exane Derivatives left its DBV Technologies S.A. American Depositary Shares share count unchanged in Q2 2022.
  • DBV Technologies S.A. American Depositary Shares made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #652 holding.
  • Exane Derivatives first reported a position in DBV Technologies S.A. American Depositary Shares in Q1 2020 and has held it in 10 quarters since.
  • Exane Derivatives's DBV Technologies S.A. American Depositary Shares position peaked at $57.1K in Q2 2020.
  • 38 funds tracked by Wall St. Rank held DBV Technologies S.A. American Depositary Shares as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.